February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...

The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...

Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

New treatments for male infertility could widen therapeutic options and possibly shift the treatment burden from women.

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the ...

We take a look at Oxford’s biotech and life sciences hub to discover what makes this historical city a hotspot for scientific innovation.

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

According to Dan Chacellor in an interview given to Pharmaceutical Commerce, the looming pharma patent cliff is set to affect up to $300 billion in drug sales by 2032. For originators, it means ...

Without Tregs, the immune system might react excessively, which could cause the body to attack its own cells. This may lead to autoimmune disease. In these cases, it is often best if the immune system ...